AGM - Our time to stand up, page-3

I've been quiet because shorters were making a mozza selling each time I predicted a rise in price. The AGM will be our time to believe again in the transformative power of gene silencing. The management have been under-promising for good reason. Multiple value-creating developments and announcements are lined up to push the share price up to a dollar and keep it there. BB-501, BB-401, sheep trial data, 5 new clinical targets with Axovant. Good luck all holders.